These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 35740009)

  • 1. Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls.
    Aranda-Rivera AK; Cruz-Gregorio A; Pedraza-Chaverri J; Scholze A
    Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases.
    Saito H
    Biochem Pharmacol; 2013 Apr; 85(7):865-72. PubMed ID: 23333765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease.
    Aminzadeh MA; Reisman SA; Vaziri ND; Shelkovnikov S; Farzaneh SH; Khazaeli M; Meyer CJ
    Redox Biol; 2013; 1(1):527-31. PubMed ID: 24363993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
    Nezu M; Suzuki N; Yamamoto M
    Am J Nephrol; 2017; 45(6):473-483. PubMed ID: 28502971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent deleterious and salutary actions of the Nrf2 inducer dh404 in chronic kidney disease.
    Vaziri ND; Liu S; Farzaneh SH; Nazertehrani S; Khazaeli M; Zhao YY
    Free Radic Biol Med; 2015 Sep; 86():374-81. PubMed ID: 25930007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of redox modulating NRF2 activators on chronic kidney disease.
    Choi BH; Kang KS; Kwak MK
    Molecules; 2014 Aug; 19(8):12727-59. PubMed ID: 25140450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippuric Acid Promotes Renal Fibrosis by Disrupting Redox Homeostasis via Facilitation of NRF2-KEAP1-CUL3 Interactions in Chronic Kidney Disease.
    Sun B; Wang X; Liu X; Wang L; Ren F; Wang X; Leng X
    Antioxidants (Basel); 2020 Aug; 9(9):. PubMed ID: 32854194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of the nuclear factor erythroid 2-related factor 2 (NRF2) system in human chronic kidney disease: alterations, interventions and relation to morbidity.
    Juul-Nielsen C; Shen J; Stenvinkel P; Scholze A
    Nephrol Dial Transplant; 2022 Apr; 37(5):904-916. PubMed ID: 33547785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-κB.
    Bolati D; Shimizu H; Yisireyili M; Nishijima F; Niwa T
    BMC Nephrol; 2013 Mar; 14():56. PubMed ID: 23496811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK3β-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition.
    Lu M; Wang P; Qiao Y; Jiang C; Ge Y; Flickinger B; Malhotra DK; Dworkin LD; Liu Z; Gong R
    Redox Biol; 2019 Sep; 26():101275. PubMed ID: 31349118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure.
    Kim HJ; Vaziri ND
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F662-71. PubMed ID: 20007347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease.
    Aminzadeh MA; Reisman SA; Vaziri ND; Khazaeli M; Yuan J; Meyer CJ
    Xenobiotica; 2014 Jun; 44(6):570-8. PubMed ID: 24195589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directly interact with Keap1 and LPS is involved in the anti-inflammatory mechanisms of (-)-epicatechin-3-gallate in LPS-induced macrophages and endotoxemia.
    Chiou YS; Huang Q; Ho CT; Wang YJ; Pan MH
    Free Radic Biol Med; 2016 May; 94():1-16. PubMed ID: 26878775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and Oxidative Stress in Chronic Kidney Disease and Dialysis Patients.
    Ebert T; Neytchev O; Witasp A; Kublickiene K; Stenvinkel P; Shiels PG
    Antioxid Redox Signal; 2021 Dec; 35(17):1426-1448. PubMed ID: 34006115
    [No Abstract]   [Full Text] [Related]  

  • 15. Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway.
    Soetikno V; Sari FR; Lakshmanan AP; Arumugam S; Harima M; Suzuki K; Kawachi H; Watanabe K
    Mol Nutr Food Res; 2013 Sep; 57(9):1649-59. PubMed ID: 23174956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf2 Protein Serum Concentration in Human CKD Shows a Biphasic Behavior.
    Rasmussen M; Hansen KH; Scholze A
    Antioxidants (Basel); 2023 Apr; 12(4):. PubMed ID: 37107307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic inflammation and oxidative stress in hemodialysis patients are associated with down-regulation of Nrf2.
    Pedruzzi LM; Cardozo LF; Daleprane JB; Stockler-Pinto MB; Monteiro EB; Leite M; Vaziri ND; Mafra D
    J Nephrol; 2015 Aug; 28(4):495-501. PubMed ID: 25585822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoxyl sulfate and p-cresyl sulfate in chronic kidney disease. Could these toxins modulate the antioxidant Nrf2-Keap1 pathway?
    Stockler-Pinto MB; Fouque D; Soulage CO; Croze M; Mafra D
    J Ren Nutr; 2014 Sep; 24(5):286-91. PubMed ID: 24480117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
    Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
    J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2-keap1 system versus NF-κB: the good and the evil in chronic kidney disease?
    Pedruzzi LM; Stockler-Pinto MB; Leite M; Mafra D
    Biochimie; 2012 Dec; 94(12):2461-6. PubMed ID: 22874821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.